Recova Pharma Expo Private Limited, a active private limited company, was established on 20 March 2006 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U99999DL2006PTC147727. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.10 M.
It upholds a compliant status. Employing 2 professional, Its leadership includes Gyanesh Jeswal (Director), Naresh Kumar Goel (Director), Ramesh Kumar Goel (Director). Past directors included Vikas Chitkara, Vikas Goel, Rajiv Kumar. It holds ₹14.19 Cr open charges and ₹9.90 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 55,56,62,63 Pocket-G Sector-4 Bawana Industrial Complex, Bawana, New Delhi, Delhi, 110039.
U99999DL2006PTC147727
147727
20 March 2006
₹3.00 M
₹1.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Recova Pharma Expo Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gyanesh Jeswal | Director | 23 Jul 2007 | Current |
| Naresh Kumar Goel | Director | 20 Mar 2006 | Current |
| Ramesh Kumar Goel | Director | 27 May 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Jul 2007 | Past |
| Pramod Abcsdd | Director | 27 Jan 2017 | Past |
| Pramod Abcsdd | Director | 25 Jul 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Recova Pharma Expo Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.18% increase. The company also saw a substantial improvement in profitability, with a 794.45% increase in profit. The company's net worth moved up by a moderate rise of 5.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Recova Pharma Expo had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹141,919,000.00
₹99,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jan 2025 | Hdfc Bank Limited | ₹1.39 Cr | Open |
| 29 Oct 2024 | Axis Bank Limited | ₹10.00 Cr | Open |
| 18 Apr 2022 | Axis Bank Limited | ₹8.00 M | Open |
| 23 Mar 2021 | Axis Bank Limited | ₹2.00 Cr | Open |
| 01 Feb 2014 | Axis Bank Limited | ₹9.90 Cr | Satisfied |
Explore comprehensive loan charge details -
Recova Pharma Expo has a workforce of 2 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Recova Pharma Expo, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recova Pharma Expo's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Recova Pharma Expo Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
The activity Recova Pharma Expo Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 13.92 M with Charge ID 101030621 was registered on 14 Jan 2025. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 100.00 M with Charge ID 101000235 was registered on 29 Oct 2024. was documented.
Progress on A charge with Axis Bank Limited amounted to Rs. 8.00 M with Charge ID 100573506 was registered on 18 Apr 2022. was documented.
Progress on A charge registered on 01 Feb 2014 via Charge ID 10476212 with Axis Bank Limited was fully satisfied on 06 Apr 2021. was documented.
The CIN of Recova Pharma Expo Private Limited is U99999DL2006PTC147727.
Recova Pharma Expo Private Limited is headquartered at 55,56,62,63 Pocket-G Sector-4 Bawana Industrial Complex, Bawana, New Delhi, Delhi, 110039.
Recova Pharma Expo Private Limited was incorporated on 20 March 2006.
The current directors of Recova Pharma Expo Private Limited are
The primary industry of Recova Pharma Expo Private Limited is Trade.
Recova Pharma Expo Private Limited is unlisted.
The authorized capital of Recova Pharma Expo Private Limited is ₹3.00 M, and the paid-up capital is ₹1.10 M.
The compliance status of Recova Pharma Expo Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX